We are live on ! Find out more
LA

Lynch & Associates Portfolio holdings

AUM $573M
1-Year Est. Return 21.74%
This Fund
S&P 500
This Quarter Est. Return
-9.73%
1 Year Est. Return
+21.74%
3 Year Est. Return
+62.9%
5 Year Est. Return
+80.86%
10 Year Est. Return
+253.69%
AUM
$268M
AUM Growth
-$28.5M
Cap. Flow
+$3.48M
Cap. Flow %
1.3%
Top 10 Hldgs %
37.03%
Holding
101
New
2
Increased
43
Reduced
32
Closed
9

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$1.63M
2
WBA
Walgreens Boots Alliance
WBA
+$1.57M
3
ABT icon
Abbott
ABT
+$1.18M
4
WMT icon
Walmart Inc
WMT
+$1.15M
5
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
+$885K

Top Sells

Rank Stock Value
1
VVC
Vectren Corporation
VVC
+$1.22M
2
SLB icon
SLB Ltd
SLB
+$777K
3
XOM icon
ExxonMobil
XOM
+$677K
4
WFC icon
Wells Fargo
WFC
+$675K
5
FITB
Fifth Third Bancorp
FITB
+$323K

Sector Composition

Rank Sector Weight
1 Healthcare 19.35%
2 Industrials 14.17%
3 Technology 13.53%
4 Consumer Staples 11.58%
5 Energy 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRBI
101
DELISTED
BLUE RIVER BANCSHARES INC
BRBI
$0 ﹤0.01%
38,072
– –
1 2 3 4
5

Similar funds

EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return
TW
Tempo Wealth Independence, Ohio $573M AUM
FRM
Fox Run Management Greenwich, Connecticut $572M AUM 24.16% 1-Year Est. Return
MAM
McLean Asset Management Tysons, Virginia $572M AUM 22% 1-Year Est. Return
IDA
Intelligence Driven Advisers Carlsbad, California $574M AUM 16.47% 1-Year Est. Return
MW
Marble Wealth Montgomery, Alabama $571M AUM
BSG
Black Swift Group Boulder, Colorado $571M AUM 36.77% 1-Year Est. Return

Lynch & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Lynch & Associates held 101 positions worth $268M, down 9.6% from $296M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Lynch & Associates's Q4 2018 filing shows 2 new, 43 increased, 32 reduced and 9 closed positions. Its largest new stake was iShares Russell Mid-Cap ETF: 4,949 shares worth $230K. The largest sale was Vectren Corporation, an estimated $1.22M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Industrials and Technology.

  • Lynch & Associates's largest Q4 2018 buy was iShares Russell Mid-Cap ETF: 4,949 shares worth $230K.
  • Lynch & Associates added most to AbbVie in Q4 2018, an estimated $1.63M increase.
  • Lynch & Associates's biggest Q4 2018 reduction was Vectren Corporation, cutting an estimated $1.22M.
  • Lynch & Associates fully exited SLB Ltd in Q4 2018, selling an estimated $777K.
  • Lynch & Associates's ten largest holdings make up 37% of its $268M portfolio in Q4 2018.
  • Lynch & Associates opened 2 new positions and closed 9 in Q4 2018.
  • Lynch & Associates's portfolio value fell 9.6% quarter-over-quarter to $268M.

Based on Lynch & Associates's 13F filing for Q4 2018, filed 10 Jan 2019.